Literature DB >> 12972029

Myeloid differentiation (MyD) primary response genes in hematopoiesis.

Dan A Liebermann1, Barbara Hoffman.   

Abstract

Myeloid differentiation (MyD) primary response and growth arrest DNA-damage (Gadd) genes comprise a set of overlapping genes, including known (IRF-1, EGR-1, Jun) and novel (MyD88, Gadd45a MyD118/Gadd45b, GADD45g, MyD116/Gadd34) genes, that have been cloned by virtue of being coordinately induced upon the onset of terminal myeloid differentiation. This review delineates the role MyD genes were found to play in blood cell development, where they function as positive regulators of terminal differentiation, lineage specific blood cell development, and control of blood cell homeostasis, including growth inhibition and apoptosis.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12972029     DOI： 10.1016/s1079-9796(03)00160-8

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN： 1079-9796            Impact factor:   3.039


  20 in total

Review 1.  Gadd45 proteins: relevance to aging, longevity and age-related pathologies.

Authors:  Alexey A Moskalev; Zeljka Smit-McBride; Mikhail V Shaposhnikov; Ekaterina N Plyusnina; Alex Zhavoronkov; Arie Budovsky; Robi Tacutu; Vadim E Fraifeld
Journal:  Ageing Res Rev       Date:  2011-10-05       Impact factor: 10.895

2.  Mouse lysocardiolipin acyltransferase controls the development of hematopoietic and endothelial lineages during in vitro embryonic stem-cell differentiation.

Authors:  Chengyan Wang; Patrick W Faloon; Zhijia Tan; Yaxin Lv; Pengbo Zhang; Yu Ge; Hongkui Deng; Jing-Wei Xiong
Journal:  Blood       Date:  2007-08-03       Impact factor: 22.113

Review 3.  Global analysis of gene expression in mammalian kidney.

Authors:  Olga Soutourina; Lydie Cheval; Alain Doucet
Journal:  Pflugers Arch       Date:  2004-12-21       Impact factor: 3.657

4.  Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle.

Authors:  Atsushi Asakura; Hiroyuki Hirai; Boris Kablar; Shigeru Morita; Jeff Ishibashi; Bryan A Piras; Amanda J Christ; Mayank Verma; Karin A Vineretsky; Michael A Rudnicki
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-10       Impact factor: 11.205

5.  miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia.

Authors:  Amanda J Favreau; Pradeep Sathyanarayana
Journal:  Leuk Res       Date:  2011-10-19       Impact factor: 3.156

6.  Expression profiling after activation of amino acid deprivation response in HepG2 human hepatoma cells.

Authors:  Jixiu Shan; Maria-Cecilia Lopez; Henry V Baker; Michael S Kilberg
Journal:  Physiol Genomics       Date:  2010-03-09       Impact factor: 3.107

7.  Rebamipide, a gastro-protective drug, inhibits indomethacin-induced apoptosis in cultured rat gastric mucosal cells: association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression.

Authors:  Yuji Naito; Hirokazu Kajikawa; Katsura Mizushima; Makoto Shimozawa; Masaaki Kuroda; Kazuhiro Katada; Tomohisa Takagi; Osamu Handa; Satoshi Kokura; Hiroshi Ichikawa; Norimasa Yoshida; Hirofumi Matsui; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

8.  MyD88 provides a protective role in long-term radiation-induced lung injury.

Authors:  Willie J Brickey; Isabel P Neuringer; William Walton; Xiaoyang Hua; Ellis Y Wang; Sushmita Jha; Gregory D Sempowski; Xuebin Yang; Suzanne L Kirby; Stephen L Tilley; Jenny P-Y Ting
Journal:  Int J Radiat Biol       Date:  2012-02-06       Impact factor: 2.694

9.  Gadd45β is an inducible coactivator of transcription that facilitates rapid liver growth in mice.

Authors:  Jianmin Tian; Haiyan Huang; Barbara Hoffman; Dan A Liebermann; Giovanna M Ledda-Columbano; Amedeo Columbano; Joseph Locker
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

10.  Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif.

Authors:  E R Yassin; A M Abdul-Nabi; A Takeda; N R Yaseen
Journal:  Leukemia       Date:  2010-03-25       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.